Athira Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 540.30 K | $2.24 M | 100.00% | 13.70% |
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 323.07 K | $1.34 M | 100.00% | 8.19% |
| VANGUARD GROUP INC | 11/07/2025 | 153.79 K | $636.69 K | 100.00% | 3.90% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 149.28 K | $618.02 K | 100.00% | 3.79% |
| PROPEL BIO MANAGEMENT, LLC | 11/12/2025 | 149.28 K | $618.02 K | 100.00% | 3.79% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 60.00 K | $248.39 K | 100.00% | 1.52% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 51.92 K | $214.97 K | 100.00% | 1.32% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 40.19 K | $165.00 K | 100.00% | 1.02% |
| PATHSTONE HOLDINGS, LLC | 11/13/2025 | 38.61 K | $159.83 K | 100.00% | 0.98% |
| BLACKROCK, INC. | 11/12/2025 | 37.64 K | $155.84 K | 100.00% | 0.95% |
| CITADEL ADVISORS LLC | 11/14/2025 | 33.99 K | $140.71 K | 100.00% | 0.86% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 32.61 K | $135.02 K | 100.00% | 0.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 30.59 K | $126.69 K | 100.00% | 0.78% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 20.99 K | $86.88 K | 100.00% | 0.53% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 14.86 K | $61.52 K | 100.00% | 0.38% |
| STATE STREET CORP | 11/14/2025 | 10.74 K | $44.45 K | 100.00% | 0.27% |
| LAIRD NORTON TRUST COMPANY, LLC | 11/14/2025 | 10.09 K | $41.76 K | 100.00% | 0.26% |
| COLONY GROUP, LLC | 11/14/2025 | 8.42 K | $558.08 K | 100.00% | 0.21% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 7.01 K | $29.58 K | 100.00% | 0.18% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.00 K | $380 | -98.34% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 638 | $2.64 K | 100.00% | 0.02% |
| MORGAN STANLEY | 11/14/2025 | 510 | $2.11 K | 100.00% | 0.01% |
| AMERICAN CAPITAL ADVISORY, LLC | 10/28/2025 | 200 | $828 | 100.00% | 0.01% |
| ROTHSCHILD INVESTMENT LLC | 11/07/2025 | 150 | $621 | 100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 144 | $596 | 100.00% | 0.00% |
| MCILRATH & ECK, LLC | 10/22/2025 | 82 | $339 | 100.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 81 | $335 | 100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 52 | $215 | -89.98% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 33 | $127 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 23 | $95 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 22 | $91 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 12 | $50 | 100.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 7 | $29 | 100.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $4 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ROTHSCHILD INVESTMENT LLC | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LAIRD NORTON TRUST COMPANY, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLAIR WILLIAM & CO/IL | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Athira Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Athira Pharma, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 540,296
BML Capital Management, LLC: 323,066
VANGUARD GROUP INC: 153,789
Propel Bio Management, LLC: 149,279
Simplify Asset Management Inc.: 149,279
TANG CAPITAL MANAGEMENT LLC: 59,998
43.34% of Athira Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.29 M shares in the last 24 months. This purchase volume represents approximately $13.62 M in transactions.